These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22285968)

  • 1. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine.
    Oh Y; Wei H; Ma D; Sun X; Liew R
    Heart; 2012 Mar; 98(6):443-9. PubMed ID: 22285968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
    Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present and future challenges of induced pluripotent stem cells.
    Ohnuki M; Takahashi K
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Human-induced Pluripotent Stem Cell the Best Optimal?
    Wang F; Kong J; Cui YY; Liu P; Wen JY
    Chin Med J (Engl); 2018 Apr; 131(7):852-856. PubMed ID: 29578130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future challenges for patient-specific induced pluripotent stem cells in cardiovascular medicine.
    Sun X; Tan G; Liew R
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):943-5. PubMed ID: 23030280
    [No Abstract]   [Full Text] [Related]  

  • 6. Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine.
    Wong WT; Sayed N; Cooke JP
    Methodist Debakey Cardiovasc J; 2013; 9(4):206-9. PubMed ID: 24298311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steps toward safe cell therapy using induced pluripotent stem cells.
    Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
    Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.
    Nsair A; MacLellan WR
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):324-30. PubMed ID: 21371511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
    Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
    Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.
    Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induced pluripotent stem cells: a new paradigm to study human tissues].
    Sansac C; Assou S; Bouckenheimer J; Lemaître JM; De Vos J
    Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Back to the future: how human induced pluripotent stem cells will transform regenerative medicine.
    Svendsen CN
    Hum Mol Genet; 2013 Oct; 22(R1):R32-8. PubMed ID: 23945396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation, Evaluation, and Application of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.
    Lin Y; Gil CH; Yoder MC
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2014-2025. PubMed ID: 29025705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
    Csöbönyeiová M; Polák Š; Danišovič L
    Exp Biol Med (Maywood); 2015 May; 240(5):549-56. PubMed ID: 25595188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.